Previous issue | Volume 97 | ESPE2023 | Next issue

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

Card image cap
The 61st ESPE Annual Meeting will now be taking place in The Hague, The Netherlands

Rapid Free Communications

Diabetes and insulin 2

hrp0097rfc9.1 | Diabetes and insulin 2 | ESPE2023

The association of dietary glycemic index and load with insulin sensitivity and secretion from early childhood to late adolescence: the QUALITY cohort

Cattrysse Pascaline , Harnois-Leblanc Soren , Sallah Drammeh Pa , Drapeau Vicky , A. Barnett Tracie , Mathieu Marie-Ève , Suissa Karine , Benedetti Andrea , Henderson Mélanie

Introduction: With the increasing prevalence of obesity, prediabetes and type 2 diabetes (T2D) in youth are on the rise. Prevention is paramount for these multifactorial diseases. Dietary interventions targeting a reduction of dietary glycemic index (GI) and glycemic load (GL) are potential strategies for improving insulin resistance. However, the association between GI and GL and T2D risk in children remains uncertain.Objectives...

hrp0097rfc9.2 | Diabetes and insulin 2 | ESPE2023

Two new candidate genes, OGDH and FGFR1 discovered in an insulinoma from a fifteen-year-old male

Andersen Kirstine , Brusgaard Klaus , Detlefsen Sönke , Christesen Henrik

The present study aimed to determine the mutational and molecular landscape of a 17 mm insulinoma from a fifteen-year-old male. Using targeted exome sequencing and microarray, we investigated somatic candidates in the insulinoma. The microarray analysis was conducted using 12 other insulinomas as a control group and revealed a total of 1907 differentially expressed genes (P-value < 0.05, FDR P-value < 0.05). After thorough gene variant filtering, we ide...

hrp0097rfc9.3 | Diabetes and insulin 2 | ESPE2023

Impaired Insulin Secretion as a Pathophysiology Underlying Abnormal Glucose Metabolism in Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors: A Study Comparing Glucose Metabolism between ALL Survivors and Simple Obese Children

Supho Warittha , Mahachoklertwattana Pat , Anurathapan Usanarat , Pongphitcha Pongpak , Kulpiya Alisa , Poomthavorn Preamrudee

Background: Pediatric acute lymphoblastic leukemia survivors (pALL-S) carry a risk for developing metabolic abnormalities, including obesity, abnormal glucose metabolism (AGM) and dyslipidemia. Previous studies showed conflicting data regarding the pathophysiology of AGM in those survivors. Additionally, there has never been a study comparing glucose metabolism between pALL-S and simple obese children (Ob-C). This study aimed to assess glucose metabolism in pA...

hrp0097rfc9.4 | Diabetes and insulin 2 | ESPE2023

Clinical and genetic characteristics of patients suspected to have Maturity-Onset Diabetes of the Young in the Czech Republic

Dusatkova Petra , Vesela Klara , Kolarova Katerina , Sumnik Zdenek , Lebl Jan , Pruhova Stepanka

Introduction: Maturity-Onset Diabetes of the Young (MODY) represents the most frequent form of monogenic diabetes. Genetic testing of Czech patients with clinical suspicion on MODY began 22 years ago. Aim of the study was to describe the prevalence of MODY subtypes among referred probands with diabetes and to define their clinical characteristics and possible differences.Methods: Clinical criteria for genetic testing of ...

hrp0097rfc9.5 | Diabetes and insulin 2 | ESPE2023

Insulin secretion defect in children and adolescents with obesity: Clinical and molecular genetic characterization

Enders-Seidlitz Helena , Raile Klemens , Galler Angela , Wiegand Susanna

Introduction: Childhood obesity shows increasing numbers worldwide and presents as a global health issue due to multiple metabolic comorbidities. About 1 % of adolescents with obesity develop type 2 diabetes (T2D), however little is known about the genetic and pathophysiological background in young age. Genome-wide association studies in adults revealed genes with increased diabetes risk, most of them regulating insulin secretion. The objective of this study w...

hrp0097rfc9.6 | Diabetes and insulin 2 | ESPE2023

Wharton jelly derived mesenchymal stem cells exosomes protect pancreatic beta cells from inflamation

Eren Simge , Yıldırım Merve , Kabataş Bilge , Ünsal Naz , Eren Olcay

Background: Type 1 diabetes is an autoimmune disease initiated by the invasion of pancreatic islets by immune cells that selectively kill the β cells. The loss of beta cells in Type I diabetes ultimately leads to insulin dependence and major complications that are difficult to manage by insulin injections. Regulation of immune response is a key strategy to control the autoimmunity in diabetic patients. Mesenchymal stem cells have been shown to have an app...